Pharmaceutical Services & Sciences

Inpatient Services Department

Solid tumor clinical pharmacists is responsible for:

  • The delivery of high quality Pharmaceutical care to all patients
  • Ensures that all practices involved in the DPS are according to the Standards and complying with JCI standards.
  • Ensures delivery of quality care to all patients in area of responsibility.
  • Ensures that all activities, transactions and practices are supporting the Vision & Mission of the CCHE.

This all done through:

  1. Adheres to the clinical Pharmacy Standards in accordance with pharmacy regulations, JCI standards and CCHE policies and procedures
  2. Build a therapeutic relationship with all patients and is the patient advocate at all levels of care
  3. Maintaining pharmaceutical care plan for all patients
  4. Reviewing protocols and guidelines in specific to treatment plans, appropriateness of use, route, dosage form, medication administration guidelines, medication dosing adjustments, pre/post/concomitant chemotherapy hydration, drug-drug interactions, food drug interaction, contraindications, required labs as they pertain to appropriate dosing, and toxicity monitoring and adjusting subsequent dosing. Also accurately identify the degree of monitoring required by a patient according to the health risks posed by the patient’s medication, drug related problems, or disease.
  5. Calculating needed compatible fluids for admixture, writing pre and post chemo hydration and adjunct medications.
  6. Routinely and accurately identify the amount and type of education desired / required by patients to maximize their chances of solving or preventing their drug related problem(s), appropriately educates patients on drug related problems
  7. Attends clinical rounds with registrar and consultant, makes the Pharmaceutical care plan for the patient and ensure updating the plan according to patient condition.
  8. Develops, implements and fulfills plans to monitor the patient's progress towards desired therapeutic outcomes
  9. Prevent, detect, monitor, document, and report adverse drug reactions and medications errors.
  10. Facilitate discharge/transfer for Pediatric Oncology patients to alternate site of care or the outpatient pharmacy, relative to drug therapy
  11. Ensure the completeness and appropriateness of restricted orders and that antimicrobial stewardship program is followed.
  12. Ensure correct and timely medication delivery and administration
  13. Developing policy and procedures for chemotherapy medication
  14. Document clinical interventions
  15. Anticipate changes in drug therapy and report the potential impact it

The In-patient Care hematology pharmacists is responsible for the delivery of high quality Pharmaceutical care to all patients,

We put knowledge into action by building our processes on evidence based practice through continuous improvement in our learning, training and exchanging knowledge with others.

The In-patient Care hematology pharmacists is responsible for:

  • Identify the risk factors, diagnosis, and general treatment approaches, protocols, roadmaps, to Common hematological pediatric malignancies. Describe the most appropriate patient-specific protocol according diagnosis, risk stratification. Identify dose; assess expected side effect and toxicities with appropriate strategies for preventing &treatment, dose modification and monitoring of each medication in patient specific protocol.

  • Collect and organize all patient-specific information needed by the pharmacist to prevent, detect, and resolve medication-related problems and to make appropriate medication therapy recommendations. Then Design clear organized pharmaceutical care plan& drug monitoring plan for each patient, Redesign monitoring plans based on evaluation of monitoring data.

  • Analyze and assess information collected and prioritize problems for provision of individualized patient care. Review new medication order prescriptions for appropriateness to patient problem list. Recommend monitoring plans to the health care team. Communicate and Interact effectively with health care teams to manage patients’ medication therapy. Maintain confidentiality of patient information. Interact effectively with patients, family members, and caregivers, then design patient-specific and caregiver-specific education. And Follow the hospital's policies and procedures to maintain the accuracy of the patient’s medication profile

In CCHE, our clinical pharmacists play an important role in the patient care system in the Intensive Care Unit (ICU). Quality caring for critically-ill patients is a standard by which a healthcare facility is evaluated , and the presence of well-trained pharmacy individuals in the process raise the standards of care and minimize errors related to medication use.

The role of our pharmacists is to manage the medication process in the ICU. This includes the overall flow of medications from the availability and receipt to the administration and waste removal.

This is applied through their daily work in the area and can be summarized in the following roles:

  • Daily round with the consultants and physicians through each patient room and following the clinical updates
  • Consulting the healthcare members about the medications use
  • Modifying medications doses, routes or frequencies depending on the patients’ lab results, responses or therapeutic drug monitoring (TDM)
  • Ensuring nurses knowledge concerning medications use or administration
  • Management of medications storage and appropriate delivery to the patients rooms
  • Appropriate use of antibiotics according to the infectious diseases unit guidelines
  • 24-hour coverage of ICU patients cases and updating the medications accordingly
  • Training of the new staff of pharmacists
  • Being a part in the residency and PharmD training programs applied by CCHE to spread the clinical pharmacy application
  • Responding to and attending the Code-Blue calls and helping crucially managing the medications (use, dose and preparation) during these emergencies; examples include cardiac arrest, respiratory failure and uncontrolled convulsions

At the CCHE’s Bone Marrow Translation (BMT) Unit, treatment is undertaken in a specialized unit by a fully dedicated and experienced multidisciplinary team to ensure safe and effective care and to prevent and solve drug-related complications.

Our BMT clinical pharmacists are involved in all steps of patient care, beginning with the pre-transplantation workup and admission to the hospital, the inpatient stay, and discharge.

Our BMT clinical pharmacists play a vital role in this multidisciplinary team, which is summarized as follows:

  • Medication management:
  • During the daily rounds, as medication experts, our BMT clinical pharmacists are well-trained to manage the complex medication regimens of HSCT patients. Moreover, they are responsible for medication order reviews, drug modification recommendations, drug information consultations, the management of different transplant medications requiring therapeutic drug monitoring (TDM), and drug interactions.
    HSCT patients may develop transplant-related complications; in such cases, our BMT pharmacists assist the team with initial and secondary therapy choices based on several factors.

  • Transition of care:
  • Our BMT pharmacists play an important role in the transition of care for HSCT patients; they serve as a liaison between the medical team, the patient, and the institution's outpatient pharmacy. They collaborate closely with the rest of the hospital teams to ensure an understanding of therapy rationales and goals that may be specific to transplant care. In addition, they work with the hospital nutrition team to help patients maintain good nutrition.

  • Education:
  • A central role of our BMT pharmacists is medication-related education. They provide patient education throughout the transplant process and during post-transplantation follow-up care. Also, ensure the nursing team’s knowledge about medication administration and related precautions. As well, educating other pharmacy departments on the specialty aspects of HSCT that will assist in keeping all teams updated. Moreover, they are responsible for the training of the Pharm.D and residency program students during their rotations.

  • Quality and process improvement:
  • Our BMT pharmacists have a significant role in supporting best practices by participating in the development of policies and procedures.

  • Research:
  • As a part of the BMT study team, our BMT clinical pharmacists are engaged in various research projects that can generate data to help improve treatment outcomes.

In addition to all the previous roles, our BMT clinical pharmacists have significant impacts on economic and humanistic outcomes in the hematopoietic stem-cell transplantation setting.